Proposed Collection: Comment Request; Revision of OMB No. 0925-0001/exp. 1/30/10, “Research and Research Training Grant Applications and Related Forms”, 75121 [E8-29147]
Download as PDF
Federal Register / Vol. 73, No. 238 / Wednesday, December 10, 2008 / Notices
E-mail comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–33,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Wendy Ponton,
Director, Office of Management.
[FR Doc. E8–29202 Filed 12–9–08; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on PROD1PC66 with NOTICES
Proposed Collection: Comment
Request; Revision of OMB No. 0925–
0001/exp. 1/30/10, ‘‘Research and
Research Training Grant Applications
and Related Forms’’
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Extramural Research, the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Research
and Research Training Grant
Applications and Related Forms. Type
of Information Collection Request:
Revision, OMB 0925–0001, Expiration
Date 11/30/10. Form Numbers: PHS 398,
2590, 2271, 3734 and HHS 568.
Need and Use of Information
Collection: The application is used by
applicants to request Federal assistance
for research and research-related
training. The other related forms are
used for trainee appointment, final
invention reporting, and to relinquish
rights to a research grant.
Frequency of response: Applicants
may submit applications for published
receipt dates. If awarded, annual
progress is reported and trainees may be
appointed or reappointed.
Affected Public: Individuals or
Households; Business or other for-profit;
Not-for-profit institutions; Federal
Government; and State, Local or Tribal
Government.
Type of Respondents: Adult scientific
professionals. The annual reporting
burden is as follows:
Estimated Number of Respondents:
160,135;
Estimated Number of Responses per
Respondent: 1;
Average Burden Hours per Response:
14; and
VerDate Aug<31>2005
16:49 Dec 09, 2008
Jkt 217001
Estimated Total Annual Burden
Hours Requested: 2,251,500. The
estimated annualized cost to
respondents is $78,802,500.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Ms. Mikia Currie,
Division of Grants Policy, Office of
Policy for Extramural Research
Administration, NIH, Rockledge 1
Building, Room 3505, 6705 Rockledge
Drive, Bethesda, MD 20892–7974, or
call non-toll-free number 301–435–
0941, or E-mail your request, including
your address to: [curriem@od.nih.gov].
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: December 4, 2008.
Joe Ellis,
Director, OPERA, OER, National Institutes of
Health.
[FR Doc. E8–29147 Filed 12–9–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
75121
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville,
Maryland 20852–3804; telephone: 301/
496–7057; fax: 301/402–0220. A signed
Confidential Disclosure Agreement will
be required to receive copies of the
patent applications.
Discovery of Novel Pharmacophores
Inhibiting the Growth of
Mycobacterium tuberculosis
Description of Technology:
Tuberculosis (TB) caused by
Mycobacterium tuberculosis infects
roughly one third of the world
population and approximately 8 million
people develop TB annually. The
emergence of multi-drug resistant
(MDR) and extensively drug-resistant
(XDR) TB strains highlight the need for
new drugs against TB. The inventions
described herein are small molecules
with drug-like properties that inhibit the
growth of Mycobacterium tuberculosis.
The compounds were discovered
utilizing high-throughput screening of a
101,000 compound library. Three
hundred active compounds inhibit
Mycobacterium tuberculosis growth by
90% or greater in in vitro assays with
MIC values ranging from 1.6 to less than
0.1 micrograms/ml, and showing
minimal toxicity in tissue culture cells.
Structure similarity analyses of the
compounds reveal 44 chemical clusters
representing 250 active compounds.
Applications: Treatment of TB
infections.
Advantages: Novel drug candidates
against TB.
Development Status: In vitro data can
be provided upon request.
Market: TB therapeutics.
Inventors: Robert C. Goldman (NIAID)
et al.
Publications: Manuscript in
preparation.
Patent Status: U.S. Provisional
Application No. 61/092,710 filed 28
Aug 2008 (HHS Reference No. E–310–
2008/0–US–01).
Licensing Status: Available for
exclusive or non-exclusive licensing.
Licensing Contact: Kevin W. Chang,
Ph.D.; 301–435–5018;
changke@mail.nih.gov.
E:\FR\FM\10DEN1.SGM
10DEN1
Agencies
[Federal Register Volume 73, Number 238 (Wednesday, December 10, 2008)]
[Notices]
[Page 75121]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29147]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection: Comment Request; Revision of OMB No. 0925-
0001/exp. 1/30/10, ``Research and Research Training Grant Applications
and Related Forms''
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the Office of Extramural
Research, the National Institutes of Health (NIH) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Proposed Collection: Title: Research and Research Training Grant
Applications and Related Forms. Type of Information Collection Request:
Revision, OMB 0925-0001, Expiration Date 11/30/10. Form Numbers: PHS
398, 2590, 2271, 3734 and HHS 568.
Need and Use of Information Collection: The application is used by
applicants to request Federal assistance for research and research-
related training. The other related forms are used for trainee
appointment, final invention reporting, and to relinquish rights to a
research grant.
Frequency of response: Applicants may submit applications for
published receipt dates. If awarded, annual progress is reported and
trainees may be appointed or reappointed.
Affected Public: Individuals or Households; Business or other for-
profit; Not-for-profit institutions; Federal Government; and State,
Local or Tribal Government.
Type of Respondents: Adult scientific professionals. The annual
reporting burden is as follows:
Estimated Number of Respondents: 160,135;
Estimated Number of Responses per Respondent: 1;
Average Burden Hours per Response: 14; and
Estimated Total Annual Burden Hours Requested: 2,251,500. The
estimated annualized cost to respondents is $78,802,500.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Ms. Mikia Currie, Division of Grants Policy,
Office of Policy for Extramural Research Administration, NIH, Rockledge
1 Building, Room 3505, 6705 Rockledge Drive, Bethesda, MD 20892-7974,
or call non-toll-free number 301-435-0941, or E-mail your request,
including your address to: [curriem@od.nih.gov].
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: December 4, 2008.
Joe Ellis,
Director, OPERA, OER, National Institutes of Health.
[FR Doc. E8-29147 Filed 12-9-08; 8:45 am]
BILLING CODE 4140-01-P